http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836427-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2017-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109836427-B |
| titleOfInvention | Pyrimidopyrimidinone compounds and application thereof |
| abstract | The invention relates to a pyrimidopyrimidinone compound with a structure shown in formula (I) or pharmaceutically acceptable salt thereof or stereoisomer thereof or prodrug molecule thereof and application thereof. The pyrimidopyrimidinone compound or the pharmaceutically acceptable salt, the prodrug molecule and the medicinal composition thereof can effectively inhibit protein kinases such as CSF1R and the like, can inhibit the proliferation, migration and invasion of various tumor cells, can be used for preparing an anti-tumor medicament, and can be used for preparing medicaments for treating hyperproliferative diseases such as tumors of human beings and other mammals. |
| priorityDate | 2017-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 696.